15 Jun 2007 CIMZIA(TM) Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
15 Jun 2007 Human Genome Sciences reports that a Phase 2 study of LymphoStat-B(R) showed significant reductions in disease activity in patients with active systemic lupus erythematosus
15 Jun 2007 Algeta demonstrates targeted cancer-killing potential of novel alpha particle linked antibodies in leading medical journal Blood
15 Jun 2007 Genmab initiates ofatumumab frontline NHL study
14 Jun 2007 ENBREL Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR
13 Jun 2007 Favrille Acquires Anti-CD20 Monoclonal Antibodies from Diversa
12 Jun 2007 Viventia Biotech initiates patient treatment for Phase I trial of VB6-845 anti-cancer antibody
12 Jun 2007 NEOPHARM, Inc. Signs Exclusive License Agreement for the Use of CINTREDEKIN BESUDOTOX (IL13-PE38QQR) for the Treatment of Pulmonary Fibrosis and Asthma
12 Jun 2007 Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II Study
09 Jun 2007 Regeneron submits biologics license application To US FDA for IL-1 Tap (Rilonacept) for treatment of CAPS
08 Jun 2007 Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
08 Jun 2007 Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
07 Jun 2007 Actemra: New data confirms significant improvement of disease signs and symptoms in patients with rheumatoid arthritis
07 Jun 2007 Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
06 Jun 2007 Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
06 Jun 2007 Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
06 Jun 2007 Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
05 Jun 2007 Investigational cancer drug Pertuzumab shows promising results in advanced breast cancer when combined with Herceptin
05 Jun 2007 ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
04 Jun 2007 Patients Who Took Investigational Melanoma Compound CP-675,206 Showed Favorable Survival Outcomes, Pfizer Says
04 Jun 2007 Genentech Provides Update on Pipeline Agents at The American Society of Clinical Oncology Meeting
04 Jun 2007 Genmab's HuMax-EGFr shows broad potential in cancer treatment
03 Jun 2007 Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients with Previously Untreated Advanced Kidney Cancer
03 Jun 2007 Results of VEGF trap (aflibercept) highlighted at ASCO 2007 annual meeting
01 Jun 2007 Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up